Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
PaperCitations, authors & open-access status
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 863 citations, 2016 year and green oa status.
863
Citations
2016
Year
green
OA Status